FCGR3A and neoplasm: However, we observed lower FcγRIIIa expression on immune cells in xenografts treated with IgG1-DE/GM, indicating that in concordance with in vitro data, tumor-associated NK cells may show reduced FcγRIIIa expression following antibody treatment (Fig. 6J).